Cypre is a biotechnology company developing tumor organoid platforms to enable more predictive oncology.
Our 3D organoids incorporate tumor, stromal, and immune components in high-throughput formats, built to replace animal models and better capture complex mechanisms of action (MOA).
Cypre’s platform supports immunotherapy development through functional insight, MOA analytics, and emerging biomarker discovery — accelerating the path toward precision medicine.
Company Details
- Employees
- 5
- Founded
- -
- Address
- 135 Mississippi St, San Francisco,california 94107,united States
- Industry
- Biotechnology
- Website
- cypre.co
- Keywords
- tumor organoids, immuno-oncology, cell therapy, bispecific antibodies, biomarker discovery, mechanism of action analysis, tumor microenvironment modeling, precision oncology, therapeutic co-development.
- HQ
- San Francisco, California
Cypre Inc. Questions
Cypre Inc.'s website is cypre.co
Cypre Inc.'s LinkedIn profile is https://www.linkedin.com/company/cypre
Cypre Inc. has
5 employees.
View email and phone details for 5
employees at Cypre Inc..
Cypre Inc.'s industry is
Biotechnology
Cypre Inc.'s top competitors are
Natera,
Pattern Biosciences,
Rezo Therapeutics,
Denali Therapeutics,
Scipro,
Exact Sciences,
Tahoe Therapeutics,
Torch Therapeutics, Inc.,
Arsenal Biosciences, Inc.,
Mission Bio.
Cypre Inc.'s categories are Biotechnology
Cypre Inc.'s founding year is 2016
